Company News: Express Scripts, Medco, Roche, Eli Lilly

Share this article:
Pharmacy benefit manager (PBM) Express Scripts said it plans to buy rival Medco Health Solutions, currently the largest PBM, for $29.1 billion. A combined company could have more pull in negotiating drug prices. The planned merger comes shortly after Medco lost its biggest contract, an $11 billion account with UnitedHealth Group which had accounted for 17% of Medco's business.

Roche said sales were down 4% and 2% for the second quarter and first six months, respectively. Accounting for some of this decline were decreases in sales of cancer drug Avastin (down 7%) and leukemia med Rituxan (down 3%). Diagnostics sales were also down about 2%.

Eli Lilly reported second-quarter revenue up 9% to $6.3 billion, beating analyst consensus by 4%. Lilly did not include any significant pipeline updates in the Q2 report.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.